A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects
Clinical trial NCT05470101 · COMPLETED
Trial details
- NCT number
- NCT05470101
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-26
- Primary completion
- 2023-05-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.